IBR Inc. to Attend BIO Europe 2012

Swiss contract research organization, IBR Inc. (Institute for Biopharmaceutical Research) has today announced it will be participating at the 18th annual Bio-Europe 2012 conference. The event will take place at CCH Congress Center in Hamburg from 12-14th November.

Offering support to clients from preclinical R&D through to clinical Phase III, GLP certified IBR Inc., will be inviting delegates to meet the team and learn about the services it provides.

IBR Inc.’s Head of Business Development, Paul Helbling comments, “We are excited to be taking part in Bio-Europe 2012. We are extremely proud of what we offer and Bio-Europe gives us a great opportunity to showcase our services and create new contacts.”

About IBR Inc.
IBR inc. is the GLP certified service provider near Zürich that supports its customers from preclinical R&D through to clinical Phase III. It specialises in the development and optimization of complex methods from scratch, such as Elisa’s, in vitro enzyme activity assays and cell based assays (potency, migration, adhesion, proliferation assays etc.). In addition, it performs the method validations according to GLP and performs sample analysis in preclinical and clinical samples. IBR Inc. has been GLP compliant since 2001 and was last inspected by Swissmedic (Swiss regulatory authorities) in April 2011.

About Bio-Europe 2012
The 18th annual BIO-Europe® is Europe’s largest partnering conference, serving the global biotechnology industry. Delegates from all parts of the biotechnology value chain come to BIO-Europe to quickly identify, engage and enter into strategic relationships that drive their businesses successfully forward. Investment and collaboration opportunities developed in prior BIO-Europe conferences have produced many highly successful business partnerships. This year´s BIO-Europe partnering event will again draw upwards of 3,000 industry attendees from over 40 countries, representing close to 1,800 companies for three days of high level networking.

Contact
Paul Helbling, PhD
Head of Business Development
Tel: +41 52 366 35 23
Mobile: +41 79 964 61 86
Email: [email protected]

For more information or to discuss IBR Inc. attending BIO-Europe 2012 please contact us directly.